Confocal fluorescence microscopy for rapid evaluation of invasive tumor cellularity of inflammatory breast carcinoma core needle biopsies by Jessica Dobbs et al.
BRIEF REPORT
Confocal fluorescence microscopy for rapid evaluation of invasive
tumor cellularity of inflammatory breast carcinoma core needle
biopsies
Jessica Dobbs • Savitri Krishnamurthy •
Matthew Kyrish • Ana Paula Benveniste •
Wei Yang • Rebecca Richards-Kortum
Received: 3 July 2014 / Accepted: 24 October 2014 / Published online: 23 November 2014
 The Author(s) 2014. This article is published with open access at Springerlink.com
Abstract Tissue sampling is a problematic issue for
inflammatory breast carcinoma, and immediate evaluation
following core needle biopsy is needed to evaluate speci-
men adequacy. We sought to determine if confocal fluo-
rescence microscopy provides sufficient resolution to
evaluate specimen adequacy by comparing invasive tumor
cellularity estimated from standard histologic images to
invasive tumor cellularity estimated from confocal images
of breast core needle biopsy specimens. Grayscale confocal
fluorescence images of breast core needle biopsy speci-
mens were acquired following proflavine application. A
breast-dedicated pathologist evaluated invasive tumor cel-
lularity in histologic images with hematoxylin and eosin
staining and in grayscale and false-colored confocal images
of cores. Agreement between cellularity estimates was
quantified using a kappa coefficient. 23 cores from 23
patients with suspected inflammatory breast carcinoma
were imaged. Confocal images were acquired in an average
of less than 2 min per core. Invasive tumor cellularity
estimated from histologic and grayscale confocal images
showed moderate agreement by kappa coefficient:
j = 0.48 ± 0.09 (p \ 0.001). Grayscale confocal images
require less than 2 min for acquisition and allow for
evaluation of invasive tumor cellularity in breast core
needle biopsy specimens with moderate agreement to his-
tologic images. We show that confocal fluorescence
microscopy can be performed immediately following
specimen acquisition and could indicate the need for
additional biopsies at the initial visit.
Keywords Inflammatory breast cancer  Core needle
biopsy  Confocal fluorescence microscopy  Tissue
sampling
Introduction
Inflammatory breast carcinoma (IBC) is a rare, aggressive
type of breast cancer that is characterized clinically by
tenderness, erythema, and edema involving at least one-
third of the entire breast [1–4]. This variant of breast cancer
can be clinically mistaken for mastitis and treated with
antibiotics resulting in a delay in the recognition of
malignancy. The redness and edema of the breast is
attributed to the frequent involvement of the lymphovas-
cular channels in the breast. Pathologic diagnosis can be
made using skin punch biopsy and/or core needle biopsy
(CNB) of the affected breast. The presence of lympho-
vascular tumor emboli in the skin biopsy and invasive
mammary carcinoma in the core biopsy can establish the
diagnosis and initiate the clinical management of the
patients. Tissue sampling can be a particularly problematic
issue in IBC, since most cases present with no discrete
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mass and therefore accurate targeting of the area of breast
for image-guided CNBs can be difficult [5, 6]. Shah and
colleagues showed that sampling error can lead to inade-
quate CNB specimens, which have an insufficient amount
of tissue to make a diagnosis, in as many as 9.1 % of cases
[7]. In cases with sampling error, several more days are
required to perform repeated biopsies and histologic
assessment for additional tissue specimens [7, 8]. Imme-
diate evaluation of CNBs for assessment of tumor cellu-
larity can be extremely valuable to ensure procurement of
adequate tissue not just for diagnosis of the invasive car-
cinoma but also for ancillary studies in one setting. Touch
preparation and frozen section are the currently available
techniques for rapid evaluation of breast CNB specimen
adequacy. While touch preparation of breast CNBs can be
useful to ascertain the presence or absence of tumor cells in
the CNBs, it cannot indicate the extent of tumor cellularity
in the CNB and whether the malignancy is in situ, invasive,
or both. In addition, the process of touching and rolling the
CNBs on the glass slides may cause distortion, which
makes them less than optimal for accurate histopatholo-
gical examination. Frozen section is generally not preferred
for immediate assessment of CNBs because of loss of the
precious tissue during the cutting process. A technique is
needed to evaluate the adequacy of IBC CNB specimens as
soon as they are procured in a clinical setting, without
tissue preparation that may compromise the quality of the
core. The technique should be able to immediately indicate
to the radiologist if the area of interest has been accurately
targeted and if additional biopsies are required [7].
Several studies have established the utility of confocal
microscopy for breast tissue assessment [4, 9–12]. Schiff-
hauer and colleagues demonstrated the feasibility of con-
focal reflectance microscopy for identifying the presence of
neoplasia in unfixed breast CNB specimens in real time
[10]. We recently showed that confocal fluorescence
microscopy can be performed in a clinical setting to
acquire images of fresh breast tissue with sufficient reso-
lution to identify neoplastic and non-neoplastic breast cy-
tomorphological and architectural features [4].
The objective of this work was to determine the feasi-
bility of using confocal fluorescence microscopy in a
clinical setting to evaluate the adequacy of IBC CNB
specimens by estimating the amount of invasive tumor
cellularity in each specimen. To meet this objective, we
performed a proof-of-concept study to estimate invasive
tumor cellularity from grayscale confocal images and
confocal images that were false-colored to mimic histo-
logic staining; results were compared to the assessment
from the gold standard of histologic images obtained from
conventional light microscopic examination of formalin-
fixed and paraffin-embedded tissue sections of the core
biopsies stained by hematoxylin and eosin.
Materials and methods
Core needle biopsy specimens were obtained from patients
with clinical signs and symptoms of IBC. The protocol for
tissue acquisition was reviewed and approved by the
Institutional Review Boards at The University of Texas
MD Anderson Cancer Center and Rice University. Ultra-
sound-guided CNBs were performed per standard clinical
protocol. Single cores were prepared for confocal imaging
within 5 min of the core needle biopsy procedure; each
core was typically 1 9 4 9 12 mm3 in size. Cores were
kept moist in phosphate buffered saline (PBS) (pH 7.4)
prior to imaging. A solution of 0.01 % proflavine in sterile
PBS was applied topically to the core for approximately
1 min; proflavine is a fluorescent dye that preferentially
stains nuclei in confocal fluorescence images [13–16].
The procedure for imaging cores with confocal fluo-
rescence microscopy has been described previously [4].
Prior to imaging, a core was positioned on the microscope
stage. Each core was imaged using a scanning confocal
microscope (Vivascope 2500; Caliber Imaging and
Diagnostics Inc., Rochester, New York) at 488 nm exci-
tation with a 550 ± 44 nm bandpass filter with a 309
water immersion lens (numerical aperture = 0.8). At the
center of the 750 9 750 lm2 region of interest (ROI),
lateral resolution of the confocal microscope is 1.0 lm and
axial resolution is 5.0 lm. Initially, illumination power was
set to 2.1 mW (±0.4 mW) and adjusted to maximize signal
and avoid saturation. To create a composite image of the
core at a single axial depth, the microscope stage was
scanned in a grid pattern (maximum area:
12.2 9 12.2 mm2); composite images of cores were typi-
cally 4 9 12.2 mm2. After imaging, the cores were stored
in PBS and submitted to the IBC tissue registry for pro-
cessing, including standard histologic preparation, fixation,
and staining with hematoxylin and eosin (H&E).
Grayscale fluorescence images of cores were acquired
with the confocal microscope. The grayscale confocal
fluorescence images were false-colored to resemble histo-
logic staining by combining the experimentally determined
color values for hematoxylin and eosin reported by Gareau
[17] into a single set of color values: H = [1.3 0.75 1.88],
where [red (k = 1), green (k = 2), and blue (k = 3)]. False
color was applied to each pixel of confocal images (C) as
follows:
Cx;y;k ¼ 1  Fx;yð2  HkÞ;
where F is the grayscale confocal fluorescence image with
each pixel normalized to the maximum [17]. The individ-
ual grayscale confocal images were automatically stitched
together immediately following acquisition by the confocal
microscope to form a composite grayscale image of each
core. False-colored confocal images were manually
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stitched together, using the grayscale confocal image as a
guide, to form a composite false-colored image of each
core.
A board-certified, dedicated breast pathologist (author S.
Krishnamurthy) assessed H&E-stained slides with a 109
objective lens and evaluated confocal images at compara-
ble magnification. Invasive tumor cellularity was estimated
in three images for each core: one histologic image pre-
pared with standard fixation in neutral buffered formalin,
routinely processed and embedded in paraffin followed by
H&E staining, one composite grayscale confocal image,
and one false-colored confocal image— using standard
histologic criteria [18]. Tumor cellularity was defined as
the percentage of the core comprised of invasive breast
carcinoma [19].
A kappa coefficient was calculated for each combination
of confocal and histologic image types (histologic vs.
grayscale confocal images and histologic vs. false-colored
confocal images), in order to compare the agreement
between invasive tumor cellularity estimated from histo-
logic, grayscale confocal, and false-colored confocal ima-
ges. In this calculation of inter-rater agreement, each image
type was considered to be one ‘‘rater.’’
Results
A total of 23 cores were collected from 23 patients with
untreated, clinically suspected IBC [1] (Table 1). Twenty
of the cores contained neoplastic tissue, identified by
Table 1 Percent invasive tumor cellularity in IBC cores estimated in histologic, grayscale confocal, and false-colored confocal images. Imaging
time indicates the time to acquire a composite grayscale confocal image. The average imaging time was 01:54 mm:ss. Histologic IBC Type and
Tumor Grade indicate the histologic type of inflammatory breast cancer and tumor grade, respectively, based on histologic assessment of all





Estimated invasive tumor cellularity in images
of core needle biopsy specimens
Imaging time
(MM:SS)








Adequate 1 90 % 75–80 % 80 % 00:53 Invasive ductal carcinoma 2
2 5 % 5 % 5 % 00:53 Invasive ductal carcinoma with
mucinous carcinoma
3
3 10 % 25 % 20 % 02:41 Invasive ductal carcinoma 3
4 20 % 5 % 20 % 01:47 Invasive ductal carcinoma 2
5 75 % 75 % 20 % 02:51 Invasive ductal carcinoma 3
6 25 % 20 % 20 % 02:07 Invasive ductal carcinoma 3
7 20 % 20 % 20 % 02:54 Invasive lobular carcinoma 3
8 100 % 100 % 30 % 02:51 Invasive ductal carcinoma 3
9 5 % 5–10 % 5 % 02:51 Invasive ductal carcinoma 3
10 25–30 % 25 % 40 % 01:46 Invasive lobular carcinoma 2
11 95 % 80–95 % 90 % 02:33 Invasive ductal carcinoma 3
12 30 % 30 % 30 % 02:09 Invasive ductal carcinoma 3
13 30 % 20 % 50 % 01:01 Invasive ductal carcinoma 3
14 95 % 70 % 90 % 01:04 Invasive ductal carcinoma 3
15 80 % 75 % 90 % 01:04 Invasive ductal carcinoma with
micropapillary features
2
16 70 % 90–95 % 95 % 01:04 Invasive ductal carcinoma 3
17 20 % 10 % 10 % 01:04 Invasive ductal and lobular
carcinoma
1
18 50 % 10–15 % 15 % 02:51 Invasive lobular carcinoma 3
19 25 % 30 % 25 % 01:47 Invasive ductal carcinoma 2
20 30–40 % 40 % 20 % 01:25 Invasive ductal carcinoma 3
Inadequate 21 0 % 0 % 5 % 02:51 Invasive ductal carcinoma 3
22 0 % 0 % 0 % 01:04 Invasive ductal carcinoma 3
23 0 % 0 % 0 % 01:47 Invasive ductal carcinoma 2
H&E hematoxylin and eosin stain
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standard histologic criteria in histologic images. The
average time to acquire a composite confocal image was
1 min, 54 s (Table 1). False coloring produced confocal
images that visually resembled tissue sections stained with
hematoxylin and eosin.
Representative histologic, grayscale confocal, and false-
colored confocal images of cores that contain IBC tissue
are shown in Figs. 1 and 2. Figure 1 shows a core that
contains both neoplastic and non-neoplastic tissue, with an
estimated 25 % cellularity in the histologic image; cellu-
larity was estimated as 30 and 25 % in grayscale confocal
and false-colored confocal images, respectively. Figure 2
shows a core with 80 % cellularity estimated in the histo-
logic image, 75 % cellularity estimated in the grayscale
confocal image, and 90 % cellularity estimated in the false-
colored confocal image.
Three cores acquired from patients diagnosed with IBC
were considered to be inadequate as a result of sampling
error; the histologic image contained no neoplastic tissue
despite a clinical diagnosis of IBC. Representative images
of an inadequate core consisting of adipose tissue and no
neoplastic tissue, based on assessment of the histologic
image, are shown in Fig. 3. All three images of the core
estimated cellularity as 0 %.
Estimates of tumor cellularity based on histologic,
grayscale confocal, and false-colored confocal images for
all specimens are summarized in Table 1. Figure 4 illus-
trates the agreement between tumor cellularity estimated in
histologic and grayscale confocal images (Fig. 4a) and in
histologic and false-colored confocal images (Fig. 4b).
Each data point represents a core needle biopsy specimen
from which tumor cellularity was estimated. Dashed lines
indicate the linear fit for each set of data points and Pearson
coefficient (R2) values quantify the linear fit of the data.
Tumor cellularity estimates were more consistent between
histologic and grayscale confocal images (R2 = 0.88) than
between histologic and false-colored confocal images
(R2 = 0.61).
A kappa coefficient was calculated [20, 21] to quantify
the agreement between histologic images and either gray-
scale or false-colored images. Standard error and p values
for kappa were also quantified (Table 2). The kappa value
calculated for agreement between histologic and grayscale
confocal images indicates moderate agreement based on
defined categories for kappa values [21, 22];
j = 0.48 ± 0.09 (p \ 0.001). Agreement between histo-
logic and false-colored confocal images was fair and not
statistically significant; j = 0.28 ± 0.26 (p = 0.14).
Discussion
The objective of this work was to determine the feasibility
of using confocal fluorescence microscopy for immediate
assessment of invasive tumor cellularity of CNBs in
patients with IBC. Composite grayscale confocal images of
CNB specimens were acquired in an average time of 2 min.
Statistical analysis shows that there is a moderate
Fig. 1 Representative core with
invasive tumor and non-
neoplastic tissue (core 19);
25 % cellularity estimated by
author S.K. in histologic image
(standard H&E staining), 30 %
cellularity estimated in
grayscale confocal fluorescence
image (0.01 % proflavine
staining), and 25 % cellularity
estimated in false-colored
confocal fluorescence image
derived from grayscale image
(0.01 % proflavine staining).
The solid outlined region
indicates areas of the CNB
specimen that contain invasive
tumor. The scale bar at left is
750 lm. The insets at right
show the border between
neoplastic and non-neoplastic
tissue in the CNB specimen.
The locations of the insets are
indicated in each core by a
square with dashed lines. The
scale bar at right is 100 lm
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agreement between tumor cellularity estimated from his-
tologic images and grayscale confocal images. False-col-
oring the confocal images using a single analog for
histologic staining does not improve agreement. These
findings demonstrate that confocal fluorescence micros-
copy could be used to assess adequacy of IBC CNB
specimens. This technique may be useful to ensure pro-
curement of high-quality CNBs not only for routine
Fig. 2 Representative core with
invasive tumor (core 15); 80 %
cellularity estimated by author
S.K. in histologic image
(standard H&E staining), 75 %
cellularity estimated in
grayscale confocal fluorescence
image (0.01 % proflavine
staining), and 90 % cellularity
estimated in false-colored
confocal fluorescence image
derived from grayscale image
(0.01 % proflavine staining).
The solid outlined region
indicates areas of the CNB
specimen that contain neoplastic
tissue. The scale bar at left is
750 lm. The insets at right
show a region of neoplastic
tissue in the CNB specimen.
The locations of the insets are
indicated in each core by a
square with dashed lines. The
scale bar at right is 100 lm
Fig. 3 Representative core with
no invasive tumor (core 22);
0 % cellularity estimated by
author S.K. in histologic image
(standard H&E staining), 0 %
cellularity estimated in
grayscale confocal fluorescence
image (0.01 % proflavine
staining), and 0 % cellularity
estimated in false-colored
confocal fluorescence image
derived from grayscale image
(0.01 % proflavine staining).
This core is considered
inadequate due to sampling
error; no invasive tumor is
visible despite a clinical
indication of IBC. The scale bar
at left is 750 lm. The insets at
right show a region of non-
neoplastic tissue in the CNB
specimen. The locations of the
insets are indicated in each core
by a square with dashed lines.
The scale bar at right is 100 lm
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histopathological diagnosis but also for ancillary studies
including immunohistochemistry and molecular testing.
Of the three CNB specimens that were determined to be
inadequate by histologic assessment, one had benign lob-
ules and fibrous tissue (core #21) and two consisted com-
pletely of adipose tissue (cores #22, 23). These cores were
identified as inadequate based on tumor cellularity esti-
mated as 0–5 % in histologic, grayscale confocal, and
false-colored confocal images (Table 1). Of the 20 CNB
specimens that were determined to be adequate by histo-
logic assessment, 20 were diagnosed as invasive carci-
noma; morphological features of invasive carcinoma were
also recognized in grayscale confocal and false-colored
confocal images. One CNB specimen was diagnosed as
mucinous carcinoma (core #2) based on standard histologic
criteria [18] and was also recognized as such on the con-
focal images.
IBC is an aggressive type of breast cancer, which is
known to metastasize through the lymphatic system and
typically presents as a non-palpable lesion [1–3]. To obtain
a rapid and accurate diagnosis of IBC, there must be a
reliable method to sample tissue. Although inter-rater
agreement is typically high for histologic diagnosis [23–
26], the rate of inadequate samples is a limitation of CNB
as a sampling technique for breast cancer diagnosis [7, 8,
23, 24, 27]. Shah and colleagues showed that the rate of
sampling error leading to inadequate CNB specimens can
be as high as 9.1 % [7]. Therefore, there is a need for a
technique that can evaluate specimen adequacy [7] with a
relatively high sensitivity and specificity.
Previous studies have illustrated the feasibility of eval-
uating breast tissue specimens with confocal microscopy
[4, 9–12]. Schiffhauer and colleagues evaluated confocal
reflectance microscopy for screening unfixed breast CNB
specimens with a range of neoplastic and non-neoplastic
histologic features. Their study showed that there were
adequate morphologic and cellular features in confocal
reflectance images to allow correlation to histologic images
[10]. In this study, we chose to focus on inflammatory
breast cancer, because we wanted to determine if assess-
ment of confocal fluorescence microscopy images of fresh
cores would show which cores had insufficient tumor tissue
for diagnosis and therefore identify cases for which a
repeat biopsy was needed. Our previous work showed that
confocal fluorescence microscopy images provide suffi-
cient detail to distinguish between neoplastic breast fea-
tures, such as ductal carcinoma in situ and invasive ductal
and lobular carcinoma, and non-neoplastic breast features
including benign ducts, lobules, and hyperplasia. [4] We
characterized inter-rater agreement between pathologists
who assessed confocal fluorescence with a kappa coeffi-
cient for multiple ratings per subject. The kappa coefficient
Fig. 4 Scatterplots illustrating agreement on estimated invasive
tumor cellularity between image types. Each data point represents a
CNB specimen. Dashed lines represent the linear fit of the data.
Pearson coefficients (R2) quantify the linear fit of invasive tumor
cellularity data. a Invasive tumor cellularity estimates from grayscale
confocal images and histologic images. b Invasive tumor cellularity
estimates from false-colored confocal images and histologic images
Table 2 Inter-rater agreement of estimated invasive tumor cellularity between the types of images, quantified by the kappa coefficient and
standard error [20]. Level of agreement is based on categories described by Viera and Garrett [21]. P value was calculated using a normal
distribution
Inter-rater agreement—two techniques
Image types Kappa coefficient Standard error Level of agreement P value
Histologic versus grayscale confocal 0.477 0.088 Moderate 3.43E-08
Histologic versus false-colored confocal 0.280 0.258 Fair 0.139
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described in our previous work (0.51, p \ 0.001) between
pathologists assessing confocal images indicated moderate
agreement based on defined categories of kappa coeffi-
cients [21, 22]. This level of agreement is similar to the
moderate agreement between a single rater’s assessment of
grayscale confocal and histologic images shown in Table 2
(0.477, p \ 0.001). The findings of these two studies sug-
gest that confocal fluorescence images could potentially be
used to assess adequacy of breast core needle biopsies with
many histologic features.
False coloring to mimic histologic staining in confocal
images of breast tissue has been demonstrated in two
studies [17, 28]. Gareau showed that the false-coloring
technique using confocal reflectance and fluorescence
microscopy to mimic hematoxylin and eosin staining,
respectively, produced multimodal confocal images mim-
icking the appearance of corresponding histologic images
[17]. Bini and colleagues used false coloring for tissue
obtained from Mohs skin excisions and demonstrated
correlation between confocal mosaics and histologic ima-
ges [28]. Previous studies showed that false coloring
improved correlation between confocal and histologic
images [21, 22]. However, in contrast to the previous
studies which used both reflectance and fluorescence ima-
ges to mimic hematoxylin and eosin staining, we used only
fluorescence images to mimic histologic staining of the
tissue section. It was not possible to use multimodal con-
focal images because reflectance images were not collected
for every CNB specimen and because some confocal
reflectance images were not aligned laterally or axially
with the confocal fluorescence images of the corresponding
core needle biopsy specimen.
In conclusion, we present the results of a proof-of-
concept study comparing estimated invasive tumor cellu-
larity between grayscale confocal, false-colored confocal,
and histologic images of 23 IBC CNB specimens. Gray-
scale confocal images require an average of only 2 min for
acquisition and allow immediate evaluation of invasive
tumor cellularity in IBC CNB specimens; agreement with
histologic images is moderate. We show that confocal
fluorescence microscopy could be used for immediate
assessment of CNB specimen adequacy, so that additional
biopsies for diagnosis, bio-banking, or genetic sequencing
studies can be performed on site without need for a repeat
visit. Additional larger prospective studies are warranted to
validate our findings for the potential utilization of confo-
cal fluorescence microscopy in routine pathology practice
as a robust technique for immediate assessment of speci-
men adequacy of IBC CNBs.
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